Medicover AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was EUR 368.6 million compared to EUR 335 million a year ago. Net loss was EUR 3.6 million compared to net income of EUR 18.3 million a year ago. Basic loss per share from continuing operations was EUR 0.024 compared to basic earnings per share from continuing operations of EUR 0.123 a year ago.
For the nine months, sales was EUR 1,112.5 million compared to EUR 1,001.1 million a year ago. Net income was EUR 10.2 million compared to EUR 74.3 million a year ago. Basic earnings per share from continuing operations was EUR 0.069 compared to EUR 0.501 a year ago.